A recent study reveals that individuals who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro can put back on lost weight far faster than those who halt traditional lifestyle regimens.
Research printed in a prominent health publication points out that while overweight individuals can lose a large proportion of their total mass while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals using such treatments must be cognizant of the danger of quick weight regain when the therapy ends," cautioned researcher Dr. Susan Jebb.
Such speed of recovery means a reversion to pre-treatment mass in about 18 months.
Analyzing Therapies
The research, which examined dozens of studies involving thousands of patients, contrasted the results of GLP-1 agonists with other pills.
Scientists note that individuals who shed pounds through diet and exercise usually see a less rapid weight regain—perhaps 100 grams monthly—once they finish.
Explaining the Rapid Rebound
Nutrition scientists suggest the mechanism of the jabs is key to understanding the amplified rebound.
The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing the hormone levels far above than the body's typical production could lead to the system to produce less of its own natural hormone, and could reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication results in hunger is uncontrolled, making binge eating far more likely."
A Lifelong Issue?
Health authorities recommend the jabs for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
Many experts say that, due to the likelihood of weight regain, the therapy is often long-term.
This view is supported by pharmaceutical companies, who state that the findings "emphasize the long-term nature of obesity," akin to managing conditions like diabetes.
User Accounts
People who have come off the jabs explain a powerful resurgence of cravings.
"It was like a switch activating and you become extremely hungry," recalled an individual.
This difficulty is compounded if individuals have not adopted sustainable dietary or behavioural changes during treatment.
Significant Use
Figures indicate that millions of people in the UK have used these injections in the last 12 months, with desire remaining high.
- Use is higher among females than men.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, clinicians caution that while GLP-1 drugs are powerful tools for weight loss, they are not a magic fix and long-term success hinges on integrated behavioural changes.
